Details for New Drug Application (NDA): 021595
✉ Email this page to a colleague
The generic ingredient in SANCTURA is trospium chloride. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
Summary for 021595
Tradename: | SANCTURA |
Applicant: | Allergan |
Ingredient: | trospium chloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 28, 2004 | TE: | RLD: | Yes |
Complete Access Available with Subscription